EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 304 filers reported holding EDITAS MEDICINE INC in Q4 2021. The put-call ratio across all filers is 3.56 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $19,000 | -56.8% | 1,643 | -29.6% | 0.00% | – |
| Q1 2022 | $44,000 | -80.0% | 2,334 | -71.8% | 0.00% | -100.0% |
| Q4 2021 | $220,000 | -80.7% | 8,277 | -70.1% | 0.00% | -77.8% |
| Q3 2021 | $1,139,000 | -16.1% | 27,716 | +15.7% | 0.01% | -30.8% |
| Q2 2021 | $1,357,000 | +38.6% | 23,959 | +2.8% | 0.01% | +18.2% |
| Q1 2021 | $979,000 | -39.6% | 23,300 | +0.7% | 0.01% | -47.6% |
| Q4 2020 | $1,622,000 | +252.6% | 23,128 | +41.7% | 0.02% | +162.5% |
| Q3 2020 | $460,000 | +108.1% | 16,320 | +127.9% | 0.01% | +100.0% |
| Q2 2020 | $221,000 | +20.8% | 7,160 | -27.5% | 0.00% | 0.0% |
| Q1 2020 | $183,000 | -22.5% | 9,880 | +23.1% | 0.00% | 0.0% |
| Q4 2019 | $236,000 | +11700.0% | 8,025 | +7925.0% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | -95.3% | 100 | -94.4% | 0.00% | -100.0% |
| Q1 2019 | $43,000 | +2050.0% | 1,779 | +1679.0% | 0.00% | – |
| Q4 2018 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |